05Jun Date June 5, 2026 Tags Biosimilar Development, Biosimilars, CDSCO, ICH E6 R3, India UK Biosimilar Corridor, Pharmacovigilance, Regulatory affairs, UK Biosimilar Approval MHRA Approval, UK Clinical Trials Categories Clinical Research OrganizationIndia – UK Biosimilar Corridor: A Controlled Evidence PathwayIndia - UK Biosimilar Corridor: A Controlled Evidence Pathway NHS England's Commissioning Fram...